333 related articles for article (PubMed ID: 32035928)
1. Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro.
Wei D; Liao L; Wang H; Zhang W; Wang T; Xu Z
Life Sci; 2020 Apr; 247():117414. PubMed ID: 32035928
[TBL] [Abstract][Full Text] [Related]
2. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
3. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.
Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M
J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979
[TBL] [Abstract][Full Text] [Related]
4. Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice.
Naznin F; Sakoda H; Okada T; Tsubouchi H; Waise TM; Arakawa K; Nakazato M
Eur J Pharmacol; 2017 Jan; 794():37-44. PubMed ID: 27876617
[TBL] [Abstract][Full Text] [Related]
5. LMO3 reprograms visceral adipocyte metabolism during obesity.
Wagner G; Fenzl A; Lindroos-Christensen J; Einwallner E; Husa J; Witzeneder N; Rauscher S; Gröger M; Derdak S; Mohr T; Sutterlüty H; Klinglmüller F; Wolkerstorfer S; Fondi M; Hoermann G; Cao L; Wagner O; Kiefer FW; Esterbauer H; Bilban M
J Mol Med (Berl); 2021 Aug; 99(8):1151-1171. PubMed ID: 34018016
[TBL] [Abstract][Full Text] [Related]
6. Metabolic remodeling in adipocytes promotes ciliary neurotrophic factor-mediated fat loss in obesity.
Crowe S; Turpin SM; Ke F; Kemp BE; Watt MJ
Endocrinology; 2008 May; 149(5):2546-56. PubMed ID: 18276754
[TBL] [Abstract][Full Text] [Related]
7. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders.
Wang L; Teng R; Di L; Rogers H; Wu H; Kopp JB; Noguchi CT
Diabetes; 2013 Dec; 62(12):4122-31. PubMed ID: 23990359
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with teneligliptin and canagliflozin additively suppresses high-fat diet-induced body weight gain in mice with modulation of lipid metabolism-related gene expression.
Kawarasaki S; Sawazaki H; Iijima H; Takahashi H; Nomura W; Inoue K; Kawada T; Goto T
Eur J Pharmacol; 2023 May; 947():175682. PubMed ID: 36965744
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the sodium-glucose co-transporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation.
Yang X; Liu Q; Li Y; Ding Y; Zhao Y; Tang Q; Wu T; Chen L; Pu S; Cheng S; Zhang J; Zhang Z; Huang Y; Li R; Zhao Y; Zou M; Shi X; Jiang W; Wang R; He J
Br J Pharmacol; 2021 Apr; 178(8):1756-1771. PubMed ID: 33480065
[TBL] [Abstract][Full Text] [Related]
10. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
Ma C; Wang Z; Xia R; Wei L; Zhang C; Zhang J; Zhao L; Wu H; Kang L; Yang S
Biomed Pharmacother; 2021 May; 137():111344. PubMed ID: 33581653
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes.
Goto T; Lee JY; Teraminami A; Kim YI; Hirai S; Uemura T; Inoue H; Takahashi N; Kawada T
J Lipid Res; 2011 May; 52(5):873-84. PubMed ID: 21324916
[TBL] [Abstract][Full Text] [Related]
12. Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy.
Xu Z; Hu W; Wang B; Xu T; Wang J; Wei D
Yonsei Med J; 2022 Jul; 63(7):619-631. PubMed ID: 35748073
[TBL] [Abstract][Full Text] [Related]
13. Heshouwu (Polygonum multiflorum Thunb.) ethanol extract suppresses pre-adipocytes differentiation in 3T3-L1 cells and adiposity in obese mice.
Choi RY; Lee HI; Ham JR; Yee ST; Kang KY; Lee MK
Biomed Pharmacother; 2018 Oct; 106():355-362. PubMed ID: 29966981
[TBL] [Abstract][Full Text] [Related]
14. Srebp-1c/Fgf21/Pgc-1α Axis Regulated by Leptin Signaling in Adipocytes-Possible Mechanism of Caloric Restriction-Associated Metabolic Remodeling of White Adipose Tissue.
Kobayashi M; Uta S; Otsubo M; Deguchi Y; Tagawa R; Mizunoe Y; Nakagawa Y; Shimano H; Higami Y
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32664386
[TBL] [Abstract][Full Text] [Related]
15. Anti-Obesity Effects of Soy Leaf via Regulation of Adipogenic Transcription Factors and Fat Oxidation in Diet-Induced Obese Mice and 3T3-L1 Adipocytes.
Li H; Kang JH; Han JM; Cho MH; Chung YJ; Park KH; Shin DH; Park HY; Choi MS; Jeong TS
J Med Food; 2015 Aug; 18(8):899-908. PubMed ID: 25826408
[TBL] [Abstract][Full Text] [Related]
16. Promoting Effect of α-Tocopherol on Beige Adipocyte Differentiation in 3T3-L1 Cells and Rat White Adipose Tissue.
Tanaka-Yachi R; Takahashi-Muto C; Adachi K; Tanimura Y; Aoki Y; Koike T; Kiyose C
J Oleo Sci; 2017; 66(2):171-179. PubMed ID: 28154348
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of canagliflozin and exercise training on high-fat diet-fed mice.
Tanaka K; Takahashi H; Katagiri S; Sasaki K; Ohsugi Y; Watanabe K; Rasadul IMD; Mine K; Nagafuchi S; Iwata T; Eguchi Y; Anzai K
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E492-E503. PubMed ID: 32017594
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.
Wang X; Wang J; Ying C; Xing Y; Su X; Men K
BMC Pharmacol Toxicol; 2024 Jan; 25(1):7. PubMed ID: 38173037
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte-Specific Deletion of Manganese Superoxide Dismutase Protects From Diet-Induced Obesity Through Increased Mitochondrial Uncoupling and Biogenesis.
Han YH; Buffolo M; Pires KM; Pei S; Scherer PE; Boudina S
Diabetes; 2016 Sep; 65(9):2639-51. PubMed ID: 27284109
[TBL] [Abstract][Full Text] [Related]
20. Fargesin improves lipid and glucose metabolism in 3T3-L1 adipocytes and high-fat diet-induced obese mice.
Lee YS; Cha BY; Choi SS; Harada Y; Choi BK; Yonezawa T; Teruya T; Nagai K; Woo JT
Biofactors; 2012; 38(4):300-8. PubMed ID: 22674784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
